Clinical trial
A Post-marketing Study Evaluating the Presence and Concentration of BRIUMVI™ in Breast Milk (PROVIDE)
NCT06143514 is registered in ClinicalTrials.gov with TG Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-marketing Study Evaluating the Presence and Concentration of BRIUMVI™ in Breast Milk (PROVIDE)
- Lead sponsor
- TG Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 26, 2024
- Completion date
- October 31, 2026
- Enrollment
- 16 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
relapsing multiple sclerosis